Navamepent

Research use only, not for human use.

Navamepent (RX-10045) is an analog of resolvin E1 (a dietary-3 polyunsaturated fatty acid metabolite), which has potent anti-inflammatory activity that reduces corneal inflammation, epithelial damage, and accelerates corneal tissue repair.

Navamepent is an analog of naturally occurring resolvin E1 (a major dietary omega-3 polyunsaturated fatty-acid metabolite) with potent anti-inflammatory and cell survival benefits. Navamepent is highly effective against dry eye and goblet cell loss thereby accelerating tear production. Also, Navamepent can reduce corneal inflammation, epithelial damage, and accelerate corneal tissue repair. In addition, Navamepent can inhibit the release of several key proinflammatory mediators from corneal epithelial cells. Navamepent is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

——

——

——

Others

Other Targets

Others

——

——

1251537-11-7

304.38

C18H24O4

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (328.54 mM; Ultrasonic )

C(C[C@@H](C#C/C=C/C=C/[C@@H](CC#C)O)O)CC(OC(C)C)=O

——

(-20℃)

With Ice Pack

≥ 2 years